Genomics

Dataset Information

High glucose associated YTHDC1 lactaylation reduces the sensitivity of bladder cancer to enfortumab vedotin therapy


ABSTRACT: High glucose associated YTHDC1 lactaylation reduces the sensitivity of bladder cancer to enfortumab vedotin therapy

PROVIDER: PRJNA1234198 | ENA |

REPOSITORIES: ENA

Dataset's files

Source:
Action DRS
SRR32636753_1.fastq.gz Fastqsanger.gz
SRR32636753_2.fastq.gz Fastqsanger.gz
SRR32636754_1.fastq.gz Fastqsanger.gz
SRR32636754_2.fastq.gz Fastqsanger.gz
SRR32636755_1.fastq.gz Fastqsanger.gz
Items per page:
1 - 5 of 8

Similar Datasets